BDBM50619089 CHEMBL5405339

SMILES CC(C)[C@H]1CC[C@@H](N2CCC(n3c(CN)cc4ccccc43)CC2)CC1

InChI Key InChIKey=URVRUMVGVFUGLH-UHFFFAOYSA-N

Data  4 KI  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 50619089   

TargetNociceptin receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataKi:  0.230nMAssay Description:Displacement of [3H]N/OFQ from human NOP expressed in CHO cells membrane incubated for 60 mins by beta liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetMu-type opioid receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataKi:  0.810nMAssay Description:Displacement of [3H]-DAMGO from human MOP expressed in CHO cells membrane incubated for 60 mins by beta liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetNociceptin receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataEC50:  5.80nMAssay Description:Agonist activity at human NOP expressed in CHO cells membrane assessed as increase in [35S]GTPgammaS binding incubated for 60 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetMu-type opioid receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human MOP expressed in CHO cells membrane assessed as increase in [35S]GTPgammaS binding incubated for 60 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetKappa-type opioid receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataKi:  25nMAssay Description:Displacement of [3H]-U69593 from human KOP expressed in CHO cells membrane incubated for 60 mins by beta liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetDelta-type opioid receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataKi:  236nMAssay Description:Displacement of [3H]DPDPE from human DOP expressed in CHO cells membrane incubated for 60 mins by beta liquid scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetKappa-type opioid receptor(Human)
Astraea Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50619089BDBM50619089(CHEMBL5405339)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human KOP expressed in CHO cells membrane assessed as increase in [35S]GTPgammaS binding incubated for 60 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed